Sep 30, 2020
Locus Biosciences signs contract with BARDA to advance $144 million precision medicine program to develop LBP-EC01, a crPhage(TM) product
Sep 23, 2020
Esperovax Awarded New Contract With BARDA
Sep 21, 2020
Ortho Awarded BARDA Contract to Accelerate Antigen Test Development and Additional SARS-CoV-2 Antibody Test Milestones
Aug 13, 2020
Innovative Diagnostic Kits Arise from a Time of Global Turmoil
Jun 19, 2020
Empatica and BARDA Join Forces to Validate Wearable System That Detects COVID-19 Before Symptoms Appear
Jun 08, 2020
SiO2 Materials Science Receives $143 Million Contract from U.S. Government to Accelerate Capacity Scale-Up of Advanced Primary Packaging Platform for COVID-19 Vaccines and Therapeutics
May 26, 2020
Luminec Pharmaceuticals Completes NIH, BARDA Coronavirus Submission
May 14, 2020
Cellphire Announces Orphan Drug Designation of Thrombosomes® for Treatment of Acute Radiation Syndrome
Apr 27, 2020
America's Blood Centers Partners with BARDA to Expand Collection of Convalescent Plasma for COVID-19 Patients
Apr 25, 2020
DiaSorin Obtains FDA Emergency Use Authorization and BARDA Funding for SARS-CoV-2 IgG Serology Kit for COVID-19 Testing in the U.S.
Apr 20, 2020
Vela Diagnostics receives BARDA funding to develop COVID-19 tests
Apr 16, 2020
HEMEMICS Biotechnologies, Inc. Receives HHS Support to Develop Rapid Antigen, Antibody Diagnostic to Identify COVID-19 Infected Americans
Apr 16, 2020
FDA Accepts for Priority Review Biologics License Application for REGN-EB3 to Treat Ebola
Apr 02, 2020
Breakthrough Ebola Treatment Receives Contract from U.S. Government
Mar 30, 2020
Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S. Department of Health & Human Services; and Commitment to Supply One Billion Vaccines Worldwide for Emergency Pandemic Use
Feb 29, 2020
Coronavirus (COVID-19) Update: FDA Issues New Policy to Help Expedite Availability of Diagnostics
Jan 14, 2020
MBio Diagnostics Announces New Contracts with SRI
Dec 18, 2019
First Light Diagnostics Receives Additional Funding From the Biomedical Advanced Research and Development Authority (BARDA)
Nov 14, 2019
Inflammatix Announces Funding from BARDA to Advance HostDx(TM) Tests
Oct 29, 2019
Beckman Coulter receives BARDA funding to develop algorithm to aid in the early detection of sepsis*